PIK3CA Mutations in Hormone Receptor-Positive Breast Cancers: PIKing Biomarkers to Inform Adjuvant Endocrine Therapy Decisions. - PubMed - NCBI

PIK3CA Mutations in Hormone Receptor-Positive Breast Cancers: PIKing Biomarkers to Inform Adjuvant Endocrine Therapy Decisions. - PubMed - NCBI

JAMA Oncol. 2018 Jun 14. doi: 10.1001/jamaoncol.2018.1766. [Epub ahead of print]

PIK3CA Mutations in Hormone Receptor-Positive Breast Cancers: PIKing Biomarkers to Inform Adjuvant Endocrine Therapy Decisions.

Stearns V1, Park BH1.

Author information

PMID:

 

29902310

 

DOI:

 

10.1001/jamaoncol.2018.1766